Mutations in the VHL tumor suppressor gene result in constitutive expression of many hypoxia-inducible genes, at least in part because of increases in the cellular level of hypoxia-inducible transcription factor HIF1␣, which in normal cells is rapidly ubiquitinated and degraded by the proteasome under normoxic conditions. The recent observation that the VHL protein is a subunit of an Skp1-Cul1͞Cdc53-F-box (SCF)-like E3 ubiquitin ligase raised the possibility that VHL may be directly responsible for regulating cellular levels of HIF1␣ by targeting it for ubiquitination and proteolysis. In this report, we test this hypothesis directly. We report development of methods for production of the purified recombinant VHL complex and present direct biochemical evidence that it can function with an E1 ubiquitin-activating enzyme and E2 ubiquitin-conjugating enzyme to activate HIF1␣ ubiquitination in vitro. Our findings provide new insight into the function of the VHL tumor suppressor protein, and they provide a foundation for future investigations of the mechanisms underlying VHL regulation of oxygen-dependent gene expression.
T
he von Hippel-Lindau (VHL) tumor suppressor gene on chromosome 3p25.5 is mutated in most sporadic clear cell renal carcinomas and in VHL disease, an autosomal dominant familial cancer syndrome that predisposes affected individuals to a variety of tumors including clear cell renal carcinomas, cerebellar hemangioblastomas and hemangiomas, retinal angiomas, and pheochromocytomas (1, 2) . A striking feature of clear cell renal carcinomas and tumors seen in VHL disease is their high vascularity, which is believed to result at least in part from high expression of vascular endothelial growth factor (VEGF).
VEGF and other hypoxically regulated genes are repressed in normal cells under normoxic growth conditions but are strongly induced in cells deprived of oxygen. Studies carried out in several laboratories led to the discovery that clear cell renal carcinoma cells lacking a functional VHL gene constitutively express hypoxia-inducible genes like VEGF, which is believed to play a role in promoting vascularization of tumors (3) (4) (5) . These studies demonstrated that reintroduction of the wild-type VHL gene into clear cell renal carcinoma cells is sufficient to repress VEGF gene expression under normoxic conditions and to restore its normal regulation by hypoxia.
Efforts to understand how the VHL protein regulates expression of hypoxia-inducible genes have revealed that the cellular levels of hypoxia-inducible transcription factors HIF1␣ and HIF2␣ are elevated in clear cell renal carcinoma cells lacking a functional VHL gene (6) . HIF1␣ and HIF2␣ positively regulate VEGF and other hypoxia-inducible genes. Hypoxic activation of gene expression is known to result at least in part from increases in the cellular levels of HIF1␣ and HIF2␣, which are rapidly ubiquitinated and degraded by the proteasome under normoxic conditions (7) .
The recent observation that the VHL protein is a subunit of a multiprotein complex possessing associated E3 ubiquitin ligase activity raised the possibility that the VHL protein may be directly responsible for regulating cellular levels of hypoxiainducible transcription factors and may target them for ubiquitination and proteolysis (8, 9) . The VHL complex resembles the well characterized SCF (Skp1-Cul1͞Cdc53-F-box) ubiquitin ligase complexes. Known subunits of the VHL complex include Cul2, Elongins B and C, and the RING-H2 finger protein Rbx1 (also referred to as ROC1 or Hrt1) (10) (11) (12) (13) (14) (15) . Cul2 is a member of the Cullin protein family, which includes SCF subunit Cul1͞ Cdc53; Elongin C is a Skp1-like protein; Rbx1 is a subunit of both the VHL and SCF complexes, where it potently activates ubiquitination by the E1͞E2 ubiquitin-activating and -conjugating enzymes; and the VHL protein has been proposed to function similarly to F-box proteins, which bind to and recruit ubiquitination substrates to SCF complexes (16, 17) .
In this report, we test the hypothesis that the VHL complex is capable of supporting ubiquitination of hypoxia-inducible transcription factors. We report the development of methods for production of the purified, recombinant 5-subunit VHL complex and present direct biochemical evidence that the VHL complex is capable of potently activating HIF1␣ ubiquitination in vitro. Our findings shed new light on the function of the VHL tumor suppressor protein, and they provide a framework for future investigations of the mechanisms underlying oxygen-dependent regulation of gene expression.
Materials and Methods
Antibodies. Anti-VHL monoclonal antibody Ig32 was purchased from PharMingen. Anti-Cul2 and anti-Elongin C monoclonal antibodies were obtained from Transduction Laboratories (Lexington, KY). Anti-myc monoclonal antibody 9E10 was from Boehringer Mannheim. Anti-HIF1␣ monoclonal antibody H1␣67 was purchased from Novus (Littleton, CO). Anti-Flag monoclonal antibody M2 was obtained from Sigma. Anti-HPC4 monoclonal antibody (18) was provided by C. T. Esmon. Anti-Elongin B rabbit polyclonal antibody was described previously (19) .
an N-terminal myc tag and a C-terminal 6-histidine tag (20) and human Ubc3 with an N-terminal 6-histidine tag (9) were prepared as described. Mammalian ubiquitin was subcloned into pGEX4T-2 (Amersham Pharmacia). Proteins were expressed in E. coli strain BL21 (DE3) and purified by Ni 2ϩ -agarose or glutathione-Sepharose affinity chromatography. After dialysis against 40 mM Hepes-NaOH (pH 7.9), 60 mM potassium acetate, 2 mM DTT, 1 mM MgCl 2 , 0.5 mM EDTA (pH 7.9), and 10% (vol͞vol) glycerol, proteins were stored at Ϫ80°C. hUbc5a, hUbc3, E2-21K, E2-35K, and E2-24K were similarly active in accepting ubiquitin in the presence of Uba1, glutathione Stransferase (GST)-ubiqutin, and ATP (data not shown).
Expression of Recombinant Proteins in Sf21 Insect Cells. Human wild-type VHL and VHL mutants VHL and VHL[L158P], human Cul2, human Elongin B, human Elongin C, human wild-type VHL containing an N-terminal 6-histidine tag (His-VHL), human wild-type VHL and VHL [117-213] containing an N-terminal 6-histidine tag and a C-terminal FLAG tag (His-VHL-FLAG), mouse Rbx1 containing an N-terminal myc tag (myc-Rbx1), and human HIF1␣ containing N-terminal 6-histidine and HPC4 tags (His-HPC4-HIF1␣) were subcloned into pBacPAK8. Human HIF1␣ containing an N-terminal Flag tag (Flag-HIF1␣) was subcloned into pBacPAK6. Recombinant baculoviruses were generated with the BacPAK baculovirus expression system (CLONTECH). Baculoviruses encoding mouse Rbx1 containing N-terminal 6-histidine and myc tags (His-myc-Rbx1) (15) , S. cerevisiae Cln2 containing N-terminal 6-histidine and HA tags, S. cerevisiae Cdc28 containing Nterminal 6-histidine and myc tags, and S. cerevisiae Cks1 containing N-terminal 6-histidine and T7 tags (20) were described previously.
Sf21 cells were cultured at 27°C in Sf-900 II SFM with 5% FCS, penicillin (100 units͞ml), and streptomycin (100 g͞ml). Sf21 cells were infected with the recombinant baculoviruses indicated in the figures. Sixty hours after infection, cells were collected and lysed in ice-cold buffer containing 40 mM Hepes-NaOH (pH 7.9), 150 mM NaCl, 1 mM DTT, 0.5% (vol͞vol) Triton X-100, 10% (vol͞vol) glycerol, 5 g͞ml leupeptin, 5 g͞ml antipain, 5 g͞ml pepstatin A, and 5 g͞ml aprotinin. In some experiments, cells were resuspended in ice-cold buffer containing 40 mM Hepes-NaOH (pH 7.9), 150 mM NaCl, 20 mM imidazole (pH 7.9), 5 g͞ml leupeptin, 5 g͞ml antipain, 5 g͞ml pepstatin A, and 5 g͞ml aprotinin and lysed by French press (American Instruments).
Purification of the Recombinant VHL Complex from Lysates of Sf21
Insect Cells. Sf21 cells were coinfected with baculoviruses indicated in the legends to Figs. 1B and 5B. Cells were harvested and lysed by French press as described above. After centrifugation at 10,000 ϫ g for 20 min at 4°C, the resulting supernatant was mixed with 1 ml of Ni 2ϩ -agarose preequilibrated in buffer containing 40 mM Hepes-NaOH (pH 7.9), 150 mM NaCl, and 20 mM imidazole (pH 7.9). After 2 h, the Ni 2ϩ -agarose was washed three times with the same buffer and packed into a 0.8-cm-diameter column. The column was eluted stepwise with buffer containing 40 mM Hepes-NaOH (pH 7.9), 50 mM NaCl, 300 mM imidazole (pH 7.9), and 10% (vol͞vol) glycerol. A peak fraction containing the recombinant VHL complex was diluted with 40 mM Tris⅐HCl used as substrate in the ubiquitination reactions of C and D was subjected to 8% SDS͞PAGE, and proteins were visualized by Coomassie staining. His-HPC4-HIF1␣ was expressed in Sf21 cells and purified by Ni 2ϩ -agarose chromatography. (B) The recombinant VHL complex was purified as described in Materials and Methods from lysates of insect cells infected with baculoviruses encoding His-VHL, Cul2, Elongin B, Elongin C, and myc-Rbx1. Aliquots of TSK DEAE-NPR column fractions were subjected to 13% SDS͞PAGE, and proteins were visualized by Coomassie staining (Top). Aliquots of TSK DEAE-NPR column fractions were subjected to 8% or 13% SDS͞PAGE, and proteins were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using the antibodies indicated in the figure (Bottom). EloB, Elongin B; EloC, Elongin C. (C) Aliquots of TSK-DEAE-NPR column fractions indicated in the figure were assayed as described in Materials and Methods for the ability to activate HIF1␣ ubiquitination. Reactions contained Ϸ50 ng of the His-HPC4-HIF1␣ shown in A. Reaction products were subjected to 8% SDS͞PAGE, and GST-ubiquitin-HIF1␣ conjugates (GST-Ub-HIF1␣) were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using anti-HPC4 antibodies. (D) Aliquots of TSK-DEAE-NPR column fraction 25 were assayed as described in Materials and Methods for the ability to activate HIF1␣ or Cln2 ubiquitination activity in the presence and absence of Uba1, hUbc5a, GST-ubiquitin (GST-Ub), and ATP. Reactions contained Ϸ50 ng of either the His-HPC4-HIF1␣ shown in A or about 50 ng of the phosphorylated Cln2 complex. Reaction products were subjected to 8% SDS͞PAGE and transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using anti-HPC4 or anti-HA antibodies. (E) Aliquots of TSK-DEAE-NPR column fraction 25 were assayed as described in Materials and Methods for the ability to activate HIF1␣ ubiquitination activity in the presence of Uba1, GST-ubiquitin (GST-Ub), ATP, and approximately equimolar amounts of the E2 ubiquitin-conjugating enzymes shown in the figure (Ϸ100 ng hUbc5a, Ϸ200 ng hUbc3, Ϸ100 ng mE2-21K, Ϸ200 ng mE2-35K, Ϸ150 ng mE2-24K). Reactions contained Ϸ50 ng of the His-HPC4-HIF1␣ shown in A. Reaction products were subjected to 8% SDS͞PAGE, and GST-ubiquitin-HIF1␣ conjugates (GST-Ub-HIF1␣) were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using anti-HPC4 antibodies.
(pH 7.9), 1 mM DTT, 0.5 mM EDTA, and 10% (vol͞vol) glycerol and brought to a conductivity equivalent to that of buffer containing 40 mM KCl. After centrifugation at 10,000 ϫ g for 20 min at 4°C, the resulting supernatant was applied to a TSK DEAE-NPR HPLC column (4.6 mm by 35 mm; Toso-Haas) preequilibrated in buffer containing 40 mM Tris⅐HCl (pH 7.9), 40 mM KCl, 1 mM DTT, 0.5 mM EDTA, and 10% (vol͞vol) glycerol. The column was eluted at 0.2 ml͞min with a 3-ml linear gradient of 40 mM to 350 mM KCl, and 0.1-ml fractions were collected.
Immunoprecipitations and Western Blotting. Sf21 cells were infected with the baculoviruses indicated in the figures. After 60 h, cells were harvested and lysed as described above. Cell lysates were incubated with antibody and protein A Sepharose for 2 h at 4°C. Protein A Sepharose was washed three times in buffer containing 40 mM Hepes-NaOH (pH 7.9), 150 mM NaCl, 1 mM DTT, 0.5% (vol͞vol) Triton X-100. Immunoprecipitated proteins were separated by SDS͞PAGE and transferred to Hybond P membranes (Amersham Pharmacia) and visualized by Western blotting with either SuperSignal West Pico or SuperSignal West Dura chemiluminescent reagent (Pierce).
Assay of Ubiquitination in Vitro.
To assay the purified VHL complex for its ability to activate HIF1␣ or Cln2 ubiquitination, aliquots of the indicated TSK DEAE-NPR HPLC column fractions were mixed with Ϸ50 ng of Uba1, Ϸ100 ng of hUbc5a, Ϸ3 g of GST-ubiquitin, and either Ϸ50 ng of purified His-HPC4-HIF1␣ or Ϸ50 ng of phosphorylated Cln2͞Cdc28͞Cks1 complex in a 10-l reaction containing 40 mM Hepes-NaOH (pH 7.9), 60 mM potassium acetate, 2 mM DTT, 5 mM MgCl 2 , 0.5 mM EDTA (pH 7.9), 10% (vol͞vol) glycerol, and 1.5 mM ATP. Reaction mixtures were incubated for 1 h at 30°C. Phosphorylated Cln2͞Cdc28͞Cks1 complex was prepared as described (20) .
To assay immunoprecipitated VHL complexes for their ability to activate HIF1␣ ubiquitination, Sf21 cells infected with the baculoviruses indicated in the figures were lysed with ice-cold buffer containing 40 mM Hepes-NaOH (pH 7.9), 150 mM NaCl, 1 mM DTT, 0.5% (vol͞vol) Triton X-100, 10% (vol͞vol) glycerol, 5 g͞ml leupeptin, 5 g͞ml antipain, 5 g͞ml pepstatin A, and 5 g͞ml aprotinin. After centrifugation at 10,000 ϫ g for 20 min at 4°C, the supernatants were immunoprecipitated with 2 g of anti-VHL (Ig32) antibody and 10 l of protein A-Sepharose. The beads were mixed with Ϸ50 ng of Uba1, Ϸ100 ng of hUbc5a, Ϸ3 g of GST-ubiquitin, and an aliquot of lysate of Sf21 cells expressing Flag-HIF1␣ in a 20-l reaction containing 40 mM Hepes-NaOH (pH 7.9), 60 mM potassium acetate, 2 mM DTT, 5 mM MgCl 2 , 0.5 mM EDTA (pH 7.9), 10% (vol͞vol) glycerol, 1.5 mM ATP, 10 mM creatine phosphate, and 10 g of creatine phosphokinase. Reaction mixtures were incubated for 1 h at 30°C.
Results
The Purified Recombinant VHL Complex Activates HIF1␣ Ubiquitination in Vitro. To investigate the possibility that the VHL complex supports ubiquitination of HIF1␣, we reconstituted the recombinant, 5-subunit VHL complex in Sf21 cells, purified it to near homogeneity, and assayed it for its ability to stimulate HIF1␣ ubiquitination in vitro. Sf21 insect cells were coinfected with baculoviruses encoding N-terminal 6-histidine-tagged VHL (His-VHL), N-terminal myc-tagged Rbx1 (myc-Rbx1), and untagged Cul2, Elongin B, and Elongin C. The VHL complex was purified from cell lysates by consecutive Ni 2ϩ -agarose chromatography and TSK DEAE-NPR HPLC. As shown in the Coomassie-stained SDS͞polyacrylamide gel and Western blots of Fig. 1B , apparently stoichiometric amounts of Cul2, Rbx1, and Elongins B and C cofractionated closely with VHL during gradient elution from TSK DEAE-NPR. To determine whether the purified VHL complex supports HIF1␣ ubiquitination, aliquots of the DEAE-NPR column fractions were assayed in the experiment of Fig. 1C for the ability to activate HIF1␣ ubiquitination in the presence of ATP and purified recombinant GST-ubiquitin, E1 ubiquitin-activating enzyme Uba1, and the E2 ubiquitin-conjugating enzyme hUbc5a, which was previously shown to be activated by the VHL complex (9) . The HIF1␣ used as substrate for ubiquitination assays contained N-terminal 6-histidine-and HPC4-tags, and it was expressed in Sf21 cells and purified by Ni 2ϩ -agarose chromatography (Fig. 1 A) . HIF1␣ and lower electrophoretic mobility GST-ubiquitin-HIF1␣ conjugates were detected by Western blotting with anti-HPC4 antibodies. As shown in Fig. 1C, HIF1␣ ubiquitination activity closely copurified with the VHL complex. Activation of HIF1␣ ubiquitination by the VHL complex was strongly dependent on ATP, GST-ubiquitin, E1 ubiquitin-activating enzyme Uba1, and E2 ubiquitin-conjugating enzyme hUbc5a (Fig. 1D) . In addition, the VHL complex failed to activate ubiquitination of phosphorylated Cln2, a substrate for ubiquitination activated by the SCF Grr1 complex (Fig. 1D) .
The VHL complex has been shown previously to activate formation of polyubiquitin chains by the E2s hUbc3 (Cdc34) and hUbc5a, hUbc5b, and hUbc5c (8, 9) . To characterize further the requirements for HIF1␣ ubiquitination in our reconstituted system, we compared the abilities of several E2s to catalyze conjugation of GST-ubiquitin to HIF1␣. Of the E2s tested, only hUbc5a supported maximal levels of HIF1␣ ubiquitination, whereas hUbc3 (Cdc34) supported very low, but detectable, levels of HIF1␣ ubiquitination (Fig. 1E) . Whether Ubc5 group enzymes and͞or Ubc3 are the major E2s activated by the VHL complex in cells remains to be determined.
Activation of HIF1␣ Ubiquitination Depends on VHL, Cul2, Rbx1, and
the Elongin BC Complex. To investigate the contribution of individual subunits of the VHL complex to HIF1␣ ubiquitination, Sf21 cells were coinfected with various combinations of baculoviruses encoding untagged VHL, N-terminal 6-histidine-and myc-tagged Rbx1 (His-myc-Rbx1), and untagged Cul2, Elongin B, and Elongin C. VHL-containing complexes were immunoprecipitated from cell lysates with anti-VHL antibodies and analyzed (i) for the presence of individual subunits of the VHL complex by Western blotting and (ii) for their abilities to activate HIF1␣ ubiquitination in the presence of ATP and purified recombinant GST-ubiquitin, E1 ubiquitin-activating enzyme Uba1, and E2 ubiquitin-conjugating enzyme hUbc5a. Lysate of Sf21 cells overexpressing N-terminal Flag-tagged HIF1␣ was the source of HIF1␣ used as substrate in these assays. As shown in Fig. 2 , maximal activation of HIF1␣ ubiquitination was observed only in the presence of VHL-containing complexes purified from cells overexpressing all five subunits of the VHL complex. A low level of HIF1␣ ubiquitination was observed when reactions contained complexes purified from cells that were not overexpressing Elongins B and C, most likely because of the presence of a substoichiometric amount of contaminating endogenous insect cell Elongins B and C (not detectable by immunoblotting using antibodies against the mammalian cell proteins) in immunoprecipitated VHL complexes. Consistent with this possibility, VHL complexes immunoprecipitated from lysates of insect cells that were not infected with baculoviruses encoding Elongins B and C contained Cul2 (Fig. 2B) , even though entry of Cul2 into the VHL complex has been shown to depend strongly on the presence of Elongins B and C (13, 21) . Finally, we note that formation of an immunoreactive species that may correspond to HIF1␣ conjugated to a single GST-ubiquitin is stimulated by addition of control immunoprecipitates prepared from cells that do not overexpress human VHL (Fig. 2C, lane 2) . It is possible that formation of this species is due to the presence of a small amount of insect cell VHL in anti-human VHL immunoprecipitates. It seems more likely, however, that its formation is due to the presence of a contaminating activity independent of the VHL complex, because these reactions contain no detectable mammalian Cul2, Elongins B and C, or Rbx1 (Fig. 2B, lane 1) , which might be expected to immunoprecipitate with the endogenous insect cell VHL.
VHL Mutants with Decreased Affinities for Elongins B and C or HIF1␣
Exhibit Reduced Activities in HIF1␣ Ubiquitination. To investigate further the requirement for Elongin BC in stimulation of HIF1␣ ubiquitination, we compared the activities of wild-type VHL and two VHL mutants that are impaired in their abilities to bind Elongins B and C. VHL mutant VHL contains VHL residues 1 to 155, which includes most of the VHL ␤-domain, but lacks the VHL ␣-domain and its Elongin BC binding site (22) . VHL mutant VHL[L158P] contains a leucine to proline mutation in a critical residue in the Elongin BC binding site; VHL[L158P] is a naturally occurring mutant found in some VHL kindreds and VHL-associated tumors (2) .
Sf21 cells were coinfected with various combinations of baculoviruses encoding N-terminal 6-histidine-and myc-tagged Rbx1 (His-myc-Rbx1), untagged Cul2, Elongin B, Elongin C, and untagged VHL, VHL , or VHL[L158P]. VHL-containing complexes were immunoprecipitated from cell lysates with anti-VHL antibodies and analyzed (i) for the presence of individual subunits of the VHL complex by Western blotting and (ii) for their abilities to activate HIF1␣ ubiquitination in the presence of ATP, and purified recombinant GST-ubiquitin, E1 ubiquitinactivating enzyme Uba1, and E2 ubiquitin-conjugating enzyme hUbc5a. Lysate of Sf21 cells overexpressing N-terminal Flagtagged HIF1␣ was the source of HIF1␣ used as substrate in these assays. As shown in Fig. 3B , VHL mutants VHL and VHL[L158P] were severely impaired in their abilities to bind to Elongins B and C. Consistent with the previous observation that entry of Cul2 into the VHL complex depends on the presence of Elongins B and C (13, 21) , VHL mutants VHL and VHL[L158P] also failed to bind Cul2. Furthermore, VHLcontaining complexes purified from insect cells expressing VHL mutants VHL or VHL[L158P] failed to activate HIF1␣ ubiquitination above the low background level observed in the absence of VHL (Fig. 3C) , even though VHL and VHL[L158P] were able to bind HIF1␣. As shown in Fig. 4 , both VHL and VHL[L158] could be coimmunoprecipitated with HIF1␣ from lysates of Sf21 cells expressing these VHL mutants and HIF1␣.
A number of tumor-associated VHL mutations that do not significantly affect binding to Elongin B and C form a solventexposed patch on the VHL ␤ domain, which has been proposed to be important for binding to proteins targeted for ubiquitina- Fig. 2 . All subunits of the VHL complex are required for maximal activation of HIF1␣ ubiquitination. (A) Total cell lysates from Sf21 cells infected with the baculoviruses indicated in the figure were subjected to 8% or 13% SDS͞PAGE, and proteins were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using the antibodies indicated in the figure. (B) The cell lysates of A were subjected to immunoprecipitations with anti-VHL antibodies as described in Materials and Methods. The immunoprecipitates were subjected to 8% or 13% SDS͞PAGE, and proteins were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using the antibodies indicated in the figure. (C) The cell lysates of A were subjected to immunoprecipitations with anti-VHL antibodies as described in Materials and Methods. The immunoprecipitates were assayed for the ability to activate HIF1␣ ubiquitination as described in Materials and Methods. Reaction products were subjected to 8% SDS͞PAGE, and GST-ubiquitin-HIF1␣ conjugates (GST-Ub-HIF1␣) were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using anti-HIF1␣ antibodies. EloB, Elongin B; EloC, Elongin C. Fig. 3 . VHL mutants that do not bind stably to Elongins B and C do not assemble into the VHL complex and do not detectably activate HIF1␣ ubiquitination. (A) Total cell lysates from Sf21 cells infected with the baculoviruses indicated in the figure were subjected to 8% or 13% SDS͞PAGE, and proteins were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using the antibodies indicated in the figure. (B) The cell lysates of A were subjected to immunoprecipitations with anti-VHL antibodies as described in Materials and Methods. The immunoprecipitates were subjected to 8% or 13% SDS͞PAGE, and proteins were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using the antibodies indicated in the figure.
(C) The cell lysates of A were subjected to immunoprecipitations with anti-VHL antibodies as described in Materials and Methods. The immunoprecipitates were assayed for the ability to activate HIF1␣ ubiquitination as described in Materials and Methods. Reaction products were subjected to 8% SDS͞PAGE, and GST-ubiquitin-HIF1␣ conjugates (GST-Ub-HIF1␣) were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using anti-HIF1␣ antibodies. EloB, Elongin C; EloC, Elongin C. tion (22) . A portion of the ␤ domain is deleted in the VHL mutant VHL , and, as shown in Fig. 5A , VHL [117-213] binds poorly to HIF1␣ when the two proteins are coexpressed in insect cells. To determine whether VHL[117-213] is also defective in HIF1␣ ubiquitination, wild-type VHL or VHL were coexpressed in insect cells with Cul2, Elongins B and C, and Rbx1, and the resulting complexes were purified from insect cell lysates by Ni 2ϩ -agarose chromatography and TSK DEAE-NPR HPLC. As shown in Fig. 5B , both wild-type VHL and VHL[117-213] assembled into chromatographically isolable complexes containing each of the VHL complex subunits; however, complexes containing VHL were defective in their ability to support HIF1␣ ubiquitination (Fig. 5C) .
Discussion
In summary, in this report we present direct biochemical evidence that the VHL tumor suppressor complex is capable of activating hUbc5a ubiquitination of hypoxia-inducible transcription factor HIF1␣ in vitro. In light of the previous observations (i) that the cellular level of HIF1␣ is tightly regulated by ubiquitin-dependent proteolysis (7) and (ii) that HIF1␣ accumulates in cells lacking a functional VHL gene (6), our findings are consistent with the model that the VHL complex is directly responsible for HIF1␣ ubiquitination and degradation by the proteasome.
Activation of HIF1␣ ubiquitination by the VHL complex depends on its individual VHL, Cul2, Elongin, and Rbx1 subunits, which appear to perform distinct tasks in recruiting HIF1␣ and the E2 ubiquitin-conjugating enzyme to the complex. Evidence from previous studies suggests that Cul2 and Rbx1 interact to form a Cul2͞Rbx1 module that is sufficient to recruit and activate ubiquitination by members of the Ubc5 family of E2 ubiquitin-conjugating enzymes (15, (23) (24) (25) (26) . Elongins B and C form a subcomplex that functions at least in part as an adaptor that links the Cul2͞Rbx1 module to the VHL protein. In light of evidence that the VHL and HIF1␣ proteins can be coimmunoprecipitated from mammalian and insect cells, the VHL protein may be solely responsible for binding to and recruiting HIF1␣ to the VHL complex, placing HIF1␣ in close proximity to the Cul2͞Rbx1 module and its associated E2 ubiquitin-conjugating enzyme.
In these respects, the VHL complex bears a striking resemblance to the well-characterized SCF E3 ubiquitin ligase complexes (16, 17, 27) . As subunits of SCF complexes, Cul1 (or Cdc53 in S. cerevisiae) and Rbx1 interact to form a Cul1͞Rbx1 module that is capable of recruiting and activating ubiquitination of target proteins by the E2 ubiquitin-conjugating enzyme Cdc34 (23, 26) . The Elongin C-like Skp1 protein functions as an adaptor that links the Cul1͞Rbx1 module to one of several F-box proteins that bind to and recruit ubiquitination substrates to the complex (27, 28) . VHL and F-box proteins may perform similar functions as subunits of their respective VHL and SCF complexes. Notably, just as Cul1͞Skp1-containing SCF complexes rely on multiple F-box proteins to target their diverse collection of ubiquitination substrates, it is possible that at least some of the more than 20 identified Elongin BC-binding proteins will function as substrate recognition subunits (29, 30) . Interestingly, the Elongin BC-binding protein suppressor of cytokine signaling (SOCS)-1, initially identified as an inhibitor of Janus kinase (Jak) kinases (31) (32) (33) , has been shown to bind the hematopoietic-specific guanine nucleotide exchange factor Vav and target it for ubiquitin-dependent proteolysis in cells (34) . In light of this observation, it is tempting to speculate that SOCS-1 (Upper) Total cell lysates from Sf21 cells infected with the baculoviruses indicated in the figure were subjected to 8% or 13% SDS͞PAGE, and proteins were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using the antibodies indicated in the figure. (Middle and Lower) Cell lysates were subjected to immunoprecipitations with anti-VHL or anti-Flag antibodies as described in Materials and Methods. The immunoprecipitates were subjected to 8% or 13% SDS͞PAGE, and proteins were transferred to Hybond P membranes and visualized by Western blotting as described in Materials and Methods, using the antibodies indicated in the figure. . Recombinant VHL complexes were purified as described in Materials and Methods. After TSK DEAE-NPR HPLC, aliquots of peak fractions from were subjected to 13% SDS͞PAGE, and proteins were visualized by Coomassie staining. (C) Aliquots of the TSK DEAE-NPR fractions shown in B were assayed as described in Materials and Methods for the ability to activate HIF1a ubiquitination. Reactions contained Ϸ50 ng of the His-HPC4-HIF1a shown in Fig. 1 A. The reaction products were subjected to 8% SDS͞PAGE, transferred to Hybond P membranes, and visualized by Western blotting using anti-HPC4 antibody. H, His; Fl, Flag.
serves as the substrate recognition subunit of a ubiquitin ligase complex. Consistent with this possibility, we have observed that, like VHL, SOCS-1 and several other members of the SOCS-box family of Elongin BC-binding proteins can assemble into multiprotein complexes containing Cul2, Elongins B and C, and Rbx1 (T.K., R.C.C., and J.W.C., unpublished results).
Finally, we note that, in independent lines of research, Cockman et al. (35) and Ohh et al. (36) have recently shown that HIF1␣ and HIF2␣ can be ubiquitinated in a VHL-dependent manner in crude mammalian cell lysates. Together with our findings, the results of these studies should provide a solid foundation for future efforts to understand the biochemical events that underlie oxygen-dependent signal transduction via the VHL tumor suppressor complex.
